Oklahoma · 2026 Regular Session · Bill
SB 1344: Prescription drugs; creating the Insulin Access and Affordability Program; requiring certain financial support and agreement. Effective date. Emergency.
Enacted Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 1344 is a bill introduced in the Oklahoma Senate on February 2, 2026. According to its official title, it concerns: Prescription drugs; creating the Insulin Access and Affordability Program; requiring certain financial support and agreement. Effective date. Emergency. Primary sponsor: Paul Rosino (Republican), Preston Stinson (Republican). Most recent recorded action (May 5, 2026): Approved by Governor 05/01/2026.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Paul Rosino | Primary sponsor | Republican | Senate | 45 |
| Preston Stinson | Primary sponsor | Republican | House | 96 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Approved by Governor 05/01/2026
- Sent to Governor
- Signed, returned to Senate
- Enrolled, to House
- Referred for enrollment
- Signed, returned to Senate
- Third Reading, Measure and Emergency passed: Ayes: 68 Nays: 22
- Coauthored by Representative(s) Archer
- General Order
- Coauthored by Representative(s) Menz
- CR; Do Pass Health and Human Services Oversight Committee
- Coauthored by Representative(s) Waldron
Showing 12 most recent of 36 actions. Full history